Company intelligence / Profile preview

consortia

Boston, Massachusetts, USA

Ownership: Private
Development stage: Other

Overview

Consortia Therapeutics is a biotechnology company focused on developing a new class of microbiome-based therapies consisting of defined microbial consortia. Founded by PureTech Health, the company utilizes a proprietary discovery platform to identify and design groups of microbes that work synergistically to modulate the immune system. Their pipeline targets a range of conditions including inflammatory bowel disease, food allergies, and oncology. By focusing on defined consortia rather than single strains or fecal transplants, the company aims to achieve more robust, scalable, and predictable therapeutic effects.

Therapeutic areas: OncologyImmunologyGastroenterology
Modalities: Live biotherapeutic product therapyMicrobial therapy
Industry: Biotech

Beyond the preview

Go deeper on consortia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on consortia.

Explore the full profile